News Coverage 11.07.19 By: Arlene Weintraub Share on Twitter Share on Facebook Share on LinkedIn ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study Related Announcement, Press Release Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto
Announcement, Press Release Parker Institute for Cancer Immunotherapy Names Maria Olson Chief Advancement Officer